| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Chief Commerical Officer | Common Stock | 101K | $1.5M | $14.86 | May 11, 2024 | Direct |
| NEOGENOMICS INC | Chief Commerical Officer | Restricted Stock Unit | 19.2K | $286K | $14.86 | May 11, 2024 | Direct |
| NEOGENOMICS INC | Chief Commerical Officer | Performance Stock Unit | 17.9K | $266K | $14.86 | May 11, 2024 | Direct |
| NEOGENOMICS INC | Chief Commerical Officer | Stock Option (Right to Buy) | 30K | May 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | May 11, 2024 | 4 | -$34.8K | 4 | May 14, 2024 | Chief Commerical Officer |
| NEO | NEOGENOMICS INC | May 2, 2024 | 3 | $0 | 4 | May 3, 2024 | Chief Commerical Officer |
| NEO | NEOGENOMICS INC | Feb 23, 2024 | 3 | $0 | 4 | Feb 27, 2024 | President, Clinical Services |
| NEO | NEOGENOMICS INC | Dec 1, 2023 | 1 | $0 | 4 | Dec 5, 2023 | President, Clinical Services |
| NEO | NEOGENOMICS INC | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | President, Clinical Services |
| NEO | NEOGENOMICS INC | Dec 1, 2022 | 2 | $0 | 4 | Dec 5, 2022 | President, Clinical Services |
| NEO | NEOGENOMICS INC | Nov 21, 2022 | 0 | $0 | 3 | Dec 1, 2022 | President, Clinical Services |